–Three scientific abstracts via one oral and two poster presentations detail the Company’s latest clinical research findings on the therapeutic effect of TERLIVAZ for adults with HRS involving rapid reduction in kidney function1 – DUBLIN, Nov. 1, 2023 /PRNewswire/ — Mallinckrodt plc…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.